Buprenorphine And Naloxone Tablet
Product Images NDC 67296-2164

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 67296-2164). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical Structure (Buprenorphine 01)
FDA Label Image

Chemical Structure (Buprenorphine 02)

Chemical Structure (Buprenorphine 02)
FDA Label Image

Image (Buprenorphine 03)

Image (Buprenorphine 03)
FDA Label Image

Principal Display Panel (2 mg/0.5 mg Tablet Bottle Label)

Principal Display Panel (2 mg/0.5 mg Tablet Bottle Label)
FDA Label Image

Principal Display Panel (8 mg/2 mg Tablet Bottle Label)

Principal Display Panel (8 mg/2 mg Tablet Bottle Label)